Search Results 1121-1130 of 18299 for Hepatitis b

1. A Study of Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010) - Mayo Clinic

   on anti-retroviral therapy (ART). - Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) ...

2. Nonalcoholic fatty liver disease - Doctors and departments - Mayo Clinic

   Find a doctor whose last name begins with the letter B B · Find a doctor whose ... hepatitis, Acute liver failure, Autoimmune hepatitis, Amyloidosis ...

3. Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer - Mayo Clinic

   ... hepatitis B core antibody and absence of HBsAg) are eligible. Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured.

4. Clinical Trial of Upfront Haploidentical or Unrelated Donor Bmt to Restore Normal Hematopoiesis in Aplastic Anemia

   Similarly, carriers of hepatitis B (HepB) or hepatitis C (HepC) may not have a detectable viral load of HepB virus or HepC virus. Participants with HIV that ...

5. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Active hepatitis B virus (HBV) infection, defined as having a positive hepatitis B surface antigen (HBsAg) test at screening; patients with a past or ...

6. Mayo Clinic Q and A. Dr. Bashar Aqel - YouTube Audio - 08 04...

   A Mayo Clinic study previously found that livers from donors exposed to hepatitis C could safely be transplanted. Now that research is expanding to other solid ...

7. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

   Positive test result at Screening for hepatitis B surface antigen;; Active hepatitis C virus (HCV) infection (positive for HCV ribonucleic acid [RNA] at ...

8. A Study of Pembrolizumab (MK-3475) Versus Placebo in Combination with Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer - Mayo Clinic

   Has a known history of hepatitis B (defined as hepatitis B surface antigen [HbsAg] reactive) or known active hepatitis C virus (defined as HCV RNA [qualitative] ...

9. Publications - Bhavna Bhasin-Chhabra, M.B.B.S., M.D. - Mayo Clinic

   Bhasin-Chhabra B, Koratala A. Pulse of prudence: Navigating isolated lung ultrasound in hemodialysis patients. Kidney Medicine. 2024 Jun; Accepted for ...

10. Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) - Mayo Clinic

    ... Hepatitis B virus (HBV) antiviral therapy for at least 4 weeks and have ... B-cell lymphoma 2 inhibitor (BCL2i). CLL participants must have received ...